In research published in Nature Cancer, the team assessed the diagnostic test, called ORACLE, in 158 people with lung cancer as part of the Cancer Research UK-funded TRACERx study. They found that ...

ORACLE was developed in 2019 to overcome the lack of biological markers in lung cancer, which can indicate to doctors who might be at a greater risk of their cancer coming back or spreading to ...

and artificial intelligence can be leveraged to look at the blood test and find the cancers that are seriously threatening someone's health. Oracle founder Larry Ellison speaks during a news ...